Trials / Enrolling By Invitation
Enrolling By InvitationNCT05653310
Tradipitant for Functional Dyspepsia
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Tradipitant for Functional Dyspepsia
- Status
- Enrolling By Invitation
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Xiao Jing (Iris) Wang · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects of tradipitant relative to placebo on gastric motor functions, satiation, and postprandial symptoms in patients with functional dyspepsia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tradipitant | Tradipitant Capsule |
| DRUG | Placebo | Placebo Capsule |
Timeline
- Start date
- 2023-02-09
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2022-12-16
- Last updated
- 2026-01-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05653310. Inclusion in this directory is not an endorsement.